Revenue
2018
2020
2021
2022
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113.54B | $95.57B | $88.42B | $102.30B | $101.20B | $86.67B | $84.81B | $79.04B | $61.64B | $50.91B | $54.14B |
| Gross profit | $22.71B | $21.25B | $21.07B | $22.69B | $21.89B | $20.14B | $20.64B | $20.54B | $12.96B | $8.39B | $8.90B |
| Research & development | $3.14B | $3.06B | $2.80B | $2.78B | $2.58B | $2.46B | $2.45B | $4.38B | $2.64B | $1.05B | $920.0M |
| Operating expenses | $14.56B | $15.01B | $15.66B | $16.91B | $17.23B | $16.45B | $18.27B | $22.95B | $16.21B | $8.90B | $9.21B |
| Operating income | $8.15B | $6.24B | $5.41B | $5.77B | $4.66B | $3.69B | $2.37B | −$2.42B | −$3.25B | −$514.0M | −$316.0M |
| EBITDAderived | $11.18B | $9.36B | $8.71B | $8.93B | $9.21B | $9.07B | $8.51B | $6.22B | $1.69B | $2.36B | $2.66B |
| Net income | $5.94B | $4.59B | $3.39B | $2.44B | $5.56B | $3.25B | $4.62B | −$2.85B | −$1.67B | −$1.10B | −$1.22B |
| Basic EPSper diluted share | $8.79 | $6.51 | $4.71 | $3.33 | — | $4.37 | $6.38 | — | — | — | — |
| Diluted EPSper diluted share | $8.68 | $6.38 | $4.60 | $3.24 | — | $4.22 | $6.03 | — | — | — | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 | Durban Egon +1Director | SellClass C Common Stock · indirect | 213 | $400.67 | $85.3K | 0 |
| Jun 26, 2026Form 4 | Durban Egon +1Director | SellClass C Common Stock · indirect | 387 | $400.67 | $155.1K | 0 |
| Jun 26, 2026Form 4 | Durban Egon +1Director | SellClass C Common Stock · indirect | 532 | $399.38 | $212.5K | 213 |
| Jun 26, 2026Form 4 | Durban Egon +1Director | SellClass C Common Stock · indirect | 968 | $399.38 | $386.6K | 387 |
| Jun 26, 2026Form 4 | Durban Egon +1Director | SellClass C Common Stock · indirect | 284 | $398.16 | $113.1K | 745 |